Most Recent
Judge erred in finding AI can be patent inventor, Full Court says
The Full Court has overturned a landmark judgment which found artificial intelligence can be named as an inventor on patent applications, in a decision which brings Australia in line with findings from courts in the UK, US and EU.
Ex-AMA Group CEO says he’s been denied emails central to ‘hot dispute’ over loan
Car repair giant AMA Group may have a discovery fight on its hands in its lawsuit against former boss Andrew Hopkins for allegedly defrauding the company of $3 million.
Maurice Blackburn prevails in State Street appeal over Fearless Girl
Maurice Blackburn has successfully defeated an appeal of a judgment that found the law firm did not breach the intellectual property rights of US financial services giant State Street Global Advisors by displaying a replica of the world renowned Fearless Girl statue in Melbourne.
Novartis can’t appeal loss of experts in MS drug patent feud with Pharmacor
The Full Federal Court won't give Swiss pharmaceuticals giant Novartis the chance to appeal a ruling that threw out three of its four experts in a patent case against generic drug maker Pharmacor.
Novartis challenges loss of experts in spat with Pharmacor over generic Gilenya
Novartis wants to appeal a ruling in its dispute with generic drug maker Pharmacor over patents for its multiple sclerosis drug Gilenya that tossed three of its four experts out of an upcoming so-called hot tub.
‘No launch, no loss’: Judge questions damages claim in Uniden design patent feud
A judge has questioned GME’s pursuit of additional damages in its intellectual property lawsuit against Japan’s Uniden that alleges the upcoming launch by the wireless communication giant of two new CB radio products amounts to infringement of its design patent. 
Full Court deals drug companies a blow on patent term extensions
The Full Court has upheld two judgments that shortened patent term extensions granted to Merck Sharpe & Dohme and Ono Pharmaceuticals, finding the extension regime cannot be construed as achieving a "commercial outcome for a patentee".
Judge tosses Novartis experts out of ‘hot tub’ in MS drug patent dispute
A judge has slammed Novartis for putting forward four "overlapping" experts in a dispute with Pharmacor over patents for its MS drug Gilenya and thrown three of those experts out of an upcoming joint conferral, known as a "hot tub".
In-N-Out Burgers settles trade mark suit against ‘ghost kitchen’ operator
American fast food chain In-N-Out Burgers has settled a trade mark dispute with a Queensland fast food business that operates "ghost kitchens" under the name In & Out Aussie Burgers.
ASIC’s penalty against Squirrel Super ‘might be a bit light on’, court says
A judge has questioned the $55,000 penalty jointly proposed by the parties in ASIC’s case against fintech company Squirrel Super over misleading statements about returns on property statements, saying it “might be a bit light on.”